David K Armstrong

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

Eric W.F.W. Alton, David K Armstrong, Deborah Ashby et al. · The Lancet Respiratory Medicine · 2015 · 424 citations · Full text

Pharmacy, Molecular Medicine, Pharmacotherapy +17

Effect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Therapy on Liberation From Respiratory Support in Acutely Ill Children Admitted to Pediatric Critical Care Units

Padmanabhan Ramnarayan, Alvin Richards‐Belle, Laura Drikite et al. · JAMA · 2022 · 70 citations · Full text

Medicine, Pediatrics, Respiratory Therapy +17

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

Eric W.F.W. Alton, David K Armstrong, Deborah Ashby et al. · Efficacy and Mechanism Evaluation · 2016 · 45 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Contact allergy to methyldibromo glutaronitrile presenting as severe scalp seborrhoeic eczema

David K Armstrong, Harvey R. Smith, R. J. G. Rycroft · Contact Dermatitis · 1999 · 27 citations

Life Sciences, Dermatology, Immunology +13

Delayed hypersensitivity to hyaluronidase (Hyalase™) used during cataract surgery

C. Feighery, É. P. McCoy, Patrick B. Johnston et al. · Contact Dermatitis · 2007 · 23 citations

Medicine, Ophthalmology, Surgery +13